Patent US2223287A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4069216A Expired / Lapsed US ⏱️ 0.0 years remaining

Simplified methods for preparation of very high purity Factor VIII concentrate

Assignee: Edward Shanbrom Inc
•
Filing: 1976-01-30
•
Granted: 1978-01-17
•
Expires: 1996-01-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for concentrating and purifying Factor VIII by selective cold precipitation with polyols is disclosed.

Inventors

  • 👤 Edward Shanbrom

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 14:42
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/745; C07K14/755; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/829; Y10S530/83

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 39 words
In a process for preparing Factor VIII concentrate, the improvement comprising the step of holding a buffer solution containing Factor VIII and about 6% polyol at a temperature of from about 0° to about 5° C until precipitation occurs.
Claim 2
Dependent Claim 39 words
In a process for preparing Factor VIII concentrate, the improvement comprising the step of holding a buffer solution containing Factor VIII and about 6% polyol at a temperature of from about 0° to about 5° C until precipitation occurs.
Claim 3
Dependent Claim 100 words
In the process for preparing Factor VIII concentrate, the improvement comprising the step of precipitating fibrinogen selectively from a solution of plasma or plasma cryoprecipitate in buffer by the addition of about 4% by volume of polyol to said solution, concentrating the Factor VIII in the solution by increasing the polyol concentration to about 6% and holding the 6% polyol containing solution at from about 0° to about 5° until precipitation occurs and then redissolving the precipitated Factor VIII in buffer solution to yield a solution containing very high purity Factor VIII which is substantially free of contaminating foreign protein.
Claim 4
Dependent Claim 100 words
In the process for preparing Factor VIII concentrate, the improvement comprising the step of precipitating fibrinogen selectively from a solution of plasma or plasma cryoprecipitate in buffer by the addition of about 4% by volume of polyol to said solution, concentrating the Factor VIII in the solution by increasing the polyol concentration to about 6% and holding the 6% polyol containing solution at from about 0° to about 5° until precipitation occurs and then redissolving the precipitated Factor VIII in buffer solution to yield a solution containing very high purity Factor VIII which is substantially free of contaminating foreign protein.
Claim 5
Dependent Claim 28 words
The process of claim 2 wherein the source of Factor VIII is cryoprecipitate dissolved in from about 2 to about 4 times the volume thereof in citrate buffer.
Claim 6
Dependent Claim 19 words
The process of claim 3 wherein the volume ratio of the cryoprecipitate to buffer is about 1 to 3.
Claim 7
Dependent Claim 54 words
In a process for removing pyrogens from a buffer solution of Factor VIII the improvement comprising the addition of about 6% polyol to said solution and holding the resulting polyol containing solution at a temperature of from about 0° to about 5° C to thereby precipitate Factor VIII, leaving in solution the pyrogenic material.
Claim 8
Dependent Claim 54 words
In a process for removing pyrogens from a buffer solution of Factor VIII the improvement comprising the addition of about 6% polyol to said solution and holding the resulting polyol containing solution at a temperature of from about 0° to about 5° C to thereby precipitate Factor VIII, leaving in solution the pyrogenic material.
Claim 9
Dependent Claim 54 words
In the process of claim 5 the addition of polyol to buffer solutions of Factor VIII in two steps, first adding about 4% polyol followed by separation of precipitate from the solution and the addition of 2% polyol and maintaining the solution at from about 0° to 5° until precipitation of Factor VIII occurs.
Claim 10
Dependent Claim 16 words
The process of claim 5 wherein the solution contains about 1 to 3 gram percent protein.
Claim 11
Dependent Claim 73 words
In the concentration of Factor VIII the improvement comprising holding a solution of about 1 part of Factor VIII containing blook fraction obtained from plasma cryoprecipitation in about 3 parts of citrate buffer containing about 6% polyol at a temperature of from about 0° to 5° to thereby cause precipitation of Factor VIII from said solution and redissolving said Factor VIII in buffer to give a very high purity Factor VIII containing solution.
Claim 12
Dependent Claim 73 words
In the concentration of Factor VIII the improvement comprising holding a solution of about 1 part of Factor VIII containing blook fraction obtained from plasma cryoprecipitation in about 3 parts of citrate buffer containing about 6% polyol at a temperature of from about 0° to 5° to thereby cause precipitation of Factor VIII from said solution and redissolving said Factor VIII in buffer to give a very high purity Factor VIII containing solution.

References Cited (Backward Citations)

US3652530A Cited
US3631018A Cited
US3682881A Cited
US3839314A Cited
US3803115A Cited
US3973002A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-01-16 1981-07-18 1982-01-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-01-16 1985-07-18 1986-01-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-01-16 1989-07-18 1990-01-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag